Search results for: events
CMT2A in the Lab: A Closer Look at How Treatments Are Tested
What if you could watch CMT2A unfold inside a neuron? CMTA’s new partnership just made it possible, and the early findings are changing the game.
From Queen Square to Dublin 24: Professor Sinéad Murphy Joins the CMTA Centers of Excellence Network
Ireland’s top CMT expert just joined the CMTA Centers of Excellence network. Big things are happening in Dublin, and beyond.
Dallas Gains a CMTA Center of Excellence With Jaya Trivedi, MD, at UT Southwestern
CMTA proudly welcomes Jaya Trivedi, MD, of UT Southwestern Medical Center in Dallas, as its newest Center of Excellence, expanding CMT expert care in Dallas/Fort Worth. Worth.
CMTA Welcomes Catie Coman as Chief Marketing Officer
CMTA welcomes Catie Coman as Chief Marketing Officer, bringing more than 15 years of experience in patient advocacy to lead marketing and communications strategy.
ENCell Announces Phase 1b/2a Stem Cell Trial for CMT1A
Could stem cells change the path of CMT research? ENCell announces stem cell clinical trial for CMT1A.
Vanda Pharmaceuticals
Vanda is a leading global biopharmaceutical company developing important new medicines to improve the lives...
How the CMT2C Community Is Driving the Path to Treatment
How is the CMT2C community helping move research forward? A CMTA-hosted focus group on how patient voices are shaping the path to a treatment.
What Happens When Scientists Flip the Switch on PMP22?
What happens when scientists flip a hidden switch inside nerve cells? A CMTA-funded $281,339 study is testing whether this discovery could finally bring new treatment options for people with CMT1A.
FDA Meeting Could Pave the Way for First CMT Treatment
Applied Therapeutics secures FDA meeting this fall on its plan to submit govorestat for CMT-SORD. And what’s this about a free SORD test?
A New Intermediate Type of CMT has Entered the Room: Meet CMTRIE
What does it mean when a nerve conduction pattern falls between demyelinating and axonal CMT? Meet CMTRIE, a new type of CMT caused by mutations in the KCTD11 gene.
